DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clolar (Clofarabine) - Acute Lymphocytic Leukaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Acute Lymphocytic Leukaemia (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) where reactions include acute lymphocytic leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Clolar side effects in 12 year old female

Reported by a physician from Argentina on 2012-05-25

Patient: 12 year old female

Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-07-01

Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-07-01

Cytoxan
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-07-01



Possible Clolar side effects in male

Reported by a physician from Argentina on 2012-05-23

Patient: male

Reactions: Acute Lymphocytic Leukaemia, Device Related Sepsis, Vomiting, Rash Erythematous, Febrile Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: 150 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia



Possible Clolar side effects in 7 year old female

Reported by a physician from Argentina on 2012-05-15

Patient: 7 year old female

Reactions: Acute Lymphocytic Leukaemia, Pigmentation Disorder, Bone Marrow Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: 40 mg/m2, qdx5

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5

Etoposide
    Dosage: 150 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Etoposide
    Dosage: 150 mg/m2, qdx5



Possible Clolar side effects in female

Reported by a physician from United States on 2012-04-24

Patient: female, weighing 41.7 kg (91.7 pounds)

Reactions: Contusion, Skin Exfoliation, Pyrexia, Haematemesis, Oral Candidiasis, Skin Discolouration, Epistaxis, Blood Pressure Increased, Swelling Face, Stomatitis, Vomiting, Pain in Extremity, Nausea, Acute Lymphocytic Leukaemia, Renal Failure, Diarrhoea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: Promethazine; Vinorelbine; Zosyn; Linezolid; Amphojel; Meropenem; Nystatin; Norvasc; Octreotide Acetate; Dexamethasone; Vinorelbine; Caphosol; Vinorelbine; Pepcid; Zoloft; Bactrim; Caspofungin Acetate; Thiotepa; RED Blood Cells, Concentrated; Platelets; Allopurinol; Acyclovir; Solutions FOR Parenteral Nutrition; Oxycodone HCL; Neupogen; Ondansetron; Lorazepam; Zithromax; Vfend; Vancomycin; Octreotide Acetate; Topotecan; Cefepime; Imodium; Dexamethasone; D5 1 / 2 NS + KCL 20 MEQ / L; Imodium



Possible Clolar side effects in female

Reported by a physician from United States on 2012-04-11

Patient: female, weighing 41.7 kg (91.7 pounds)

Reactions: Contusion, Skin Exfoliation, Pyrexia, Haematemesis, Oral Candidiasis, Skin Discolouration, Epistaxis, Blood Pressure Increased, Swelling Face, Vomiting, Nausea, Pain in Extremity, Acute Lymphocytic Leukaemia, Mucosal Inflammation, Renal Failure, Diarrhoea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: D5 1 / 2 NS + KCL 20 MEQ / L; Vfend; Pepcid; Zoloft; Solutions FOR Parenteral Nutrition; Imodium; Thiotepa; Ondansetron; Lorazepam; Vinorelbine; Vinorelbine; Zosyn; Zithromax; Norvasc; Bactrim; Octreotide Acetate; Oxycodone HCL; Acyclovir; Caphosol; Neupogen; Promethazine; Nystatin; Platelets; Cefepime; Imodium; RED Blood Cells, Concentrated; Allopurinol; Vinorelbine; Amphojel; Meropenem; Vancomycin; Dexamethasone; Dexamethasone; Topotecan; Linezolid; Caspofungin Acetate; Octreotide Acetate



Possible Clolar side effects in male

Reported by a physician from Argentina on 2012-01-16

Patient: male

Reactions: Acute Lymphocytic Leukaemia, Fanconi Syndrome, Pyrexia, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 440 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Etoposide
    Dosage: 150 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent



Possible Clolar side effects in male

Reported by a physician from Argentina on 2012-01-16

Patient: male

Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: 40 mg/m2, qd
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Dosage: 150 mg/m2, unk
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: 440 mg/m2, unk
    Indication: Acute Lymphocytic Leukaemia



Possible Clolar side effects in male

Reported by a physician from Argentina on 2012-01-13

Patient: male

Reactions: Acute Lymphocytic Leukaemia, Fanconi Syndrome, Pyrexia, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Etoposide
    Dosage: 150 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent



Possible Clolar side effects in female

Reported by a physician from Argentina on 2012-01-12

Patient: female

Reactions: Acute Lymphocytic Leukaemia, Neoplasm Progression, Neutropenia, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: Etoposide; Cyclophosphamide



Possible Clolar side effects in male

Reported by a physician from Argentina on 2012-01-12

Patient: male

Reactions: Acute Lymphocytic Leukaemia, Drug Ineffective, Neutropenia, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: 150 mg/m2, qdx5, 1cycle
    Indication: Acute Lymphocytic Leukaemia

Clolar
    Dosage: 40 mg/m2, qdx5 1 cycle
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5 1 cycle
    Indication: Acute Lymphocytic Leukaemia



Possible Clolar side effects in 9 year old female

Reported by a physician from Argentina on 2011-10-18

Patient: 9 year old female

Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Haematotoxicity, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-03-29

Clolar
    Dosage: 40 mg/m2 x 5, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-03-29

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-03-29



Possible Clolar side effects in 10 month old female

Reported by a physician from Argentina on 2011-10-18

Patient: 10 month old female

Reactions: Acute Lymphocytic Leukaemia, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: 40 mg/m2 x 5, unk
    Indication: Acute Lymphocytic Leukaemia Recurrent
    Start date: 2011-02-05

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia Recurrent
    Start date: 2011-02-05

Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia Recurrent
    Start date: 2011-02-05



Possible Clolar side effects in 5 year old female

Reported by a consumer/non-health professional from Argentina on 2011-10-17

Patient: 5 year old female

Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Haematotoxicity

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-12-02



Possible Clolar side effects in 8 year old male

Reported by a physician from Argentina on 2011-10-12

Patient: 8 year old male

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-03-01

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-03-01

Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-03-01



Possible Clolar side effects in 7 year old female

Reported by a physician from Argentina on 2011-10-04

Patient: 7 year old female

Reactions: Acute Lymphocytic Leukaemia, Disease Recurrence, Neoplasm Progression, Aplasia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia



Possible Clolar side effects in 3 year old male

Reported by a physician from Argentina on 2011-10-03

Patient: 3 year old male

Reactions: Acute Lymphocytic Leukaemia, Drug Ineffective

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017